The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
In utero exposure to valproic acid and autism — A current review of clinical and animal studies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., Piven, J., & Crawley, J. N. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-1848.2004.00076.x · Cited by 1,522 · cited 2×
“a Three chamber social behavior apparatus is an established tool for testing sociability and social novelty (Moy et al., 2004); for sociability test, chamber 1 contains a stranger mouse or rat in an inverted cup, the center chamber is empty, and chamber 2 contains an empty inverted cup; for social novelty, chamber 1 c…”
MethodEpidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update
Fombonne, E. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025054610557 · Cited by 1,505
Behavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism
Schneider, T., & Przewłocki, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300518 · Cited by 959
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803531 · Cited by 812
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., & Vajda, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70107-7 · Cited by 751
Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
Jentink, J., Loane, M. A., Dolk, H., Barisic, I., Garne, E., Morris, J. K., & de Jong-van den Berg, L. T. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907328 · Cited by 587
Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children
Schain, R. J., & Freedman, D. X. (1961) · The Journal of Pediatrics · doi:10.1016/s0022-3476(61)80261-8 · Cited by 579
Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action
Löscher, W. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00075-6 · Cited by 532
Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy, A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.014 · Cited by 526
Designing mouse behavioral tasks relevant to autistic‐like behaviors
Crawley, J. N. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20039 · Cited by 514
Characteristics of fetal anticonvulsant syndrome associated autistic disorder
Rasalam, A., Hailey, H., Williams, J., Moore, S., Turnpenny, P., Lloyd, D., & Dean, J. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205001076 · Cited by 456
Fetal valproate syndrome and autism: additional evidence of an association
Williams, G., King, J., Cunningham, M., Stephan, M., Kerr, B., & Hersh, J. H. (2001) · Developmental Medicine and Child Neurology · doi:10.1017/s001216220100038x · Cited by 422
Meador, K., Reynolds, M. W., Crean, S., Fahrbach, K., & Probst, C. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.04.022 · Cited by 400
Abnormal Fear Conditioning and Amygdala Processing in an Animal Model of Autism
Markram, K., Rinaldi, T., Mendola, D. L., Sandi, C., & Markram, H. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301453 · Cited by 382
Ingram, J. L., Peckham, S. M., Tisdale, B., & Rodier, P. M. (2000) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(99)00083-5 · Cited by 381
Brain Serotonin and Dopamine Transporter Bindings in Adults With High-Functioning Autism
Nakamura, K., Sekine, Y., Ouchi, Y., Tsujii, M., Yoshikawa, E., Futatsubashi, M., Tsuchiya, K. J., Sugihara, G., Iwata, Y., Suzuki, K., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.137 · Cited by 352
Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., & Matsuda, T. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001714 · Cited by 341
Schneider, T., Roman, A., Basta-Kaim, A., Kubera, M., Budziszewska, B., Schneider, K., & Przewłocki, R. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.02.011 · Cited by 337
Fetal Valproate Syndrome: Clinical and Neuro‐developmental Features in Two Sibling Pairs
Christianson, A. L., Chester, N., & Kromberg, J. G. R. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11858.x · Cited by 336
Veenstra-VanderWeele, J., Muller, C. L., Iwamoto, H., Sauer, J. E., Owens, W. A., Shah, C. R., Cohen, J., Mannangatti, P., Jessen, T., Thompson, B. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112345109 · Cited by 333
Validating γ oscillations and delayed auditory responses as translational biomarkers of autism
Gandal, M. J., Edgar, J. C., Ehrlichman, R. S., Mehta, M., Roberts, T. P. L., & Siegel, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.031 · Cited by 314
Schneider, T., Turczak, J., & Przewłocki, R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300767 · Cited by 302
Betancur, C., Sakurai, T., & Buxbaum, J. D. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.04.003 · Cited by 301
The critical period of valproate exposure to induce autistic symptoms in Sprague–Dawley rats
Kim, K. C., Kim, P., Go, H. S., Choi, C. S., Yang, S.-I., Cheong, J. H., Shin, C. Y., & Ko, K. H. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2010.12.018 · Cited by 284
A New Neurobehavioral Model of Autism in Mice: Pre- and Postnatal Exposure to Sodium Valproate
Wagner, G. C., Reuhl, K. R., Cheh, M., McRae, P., & Halladay, A. K. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0117-y · Cited by 277
Autism Spectrum Disorders in the Stockholm Youth Cohort: Design, Prevalence and Validity
Idring, S., Rai, D., Dal, H., Dalman, C., Sturm, H., Zander, E., Lee, B. K., Serlachius, E., & Magnusson, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041280 · Cited by 275
AUTISM SPECTRUM DISORDERS FOLLOWING IN UTERO EXPOSURE TO ANTIEPILEPTIC DRUGS
Bromley, R. L., Mawer, G., Clayton-Smith, J., & Baker, G. A. (2008) · Neurology · doi:10.1212/01.wnl.0000339399.64213.1a · Cited by 269
Harden, C. L., Meador, K. J., Pennell, P. B., Allen Hauser, W., Gronseth, G. S., French, J. A., Wiebe, S., Thurman, D., Koppel, B. S., Kaplan, P. W., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02129.x · Cited by 255
[Pharmacodynamic properties of N-dipropylacetic acid].
Meunier, H., Carraz, G., Neunier, Y., Eymard, P., & Aimard, M. (1963) · PubMed · Cited by 251
Linking etiologies in humans and animal models: Studies of autism
Rodier, P. M., Ingram, J. L., Tisdale, B., & Croog, V. J. (1997) · Reproductive Toxicology · doi:10.1016/s0890-6238(97)80001-u · Cited by 247
Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection
Monti, B., Polazzi, E., & Contestabile, A. (2009) · Current Molecular Pharmacology · doi:10.2174/1874-470210902010095 · Cited by 239
Autism Spectrum Disorders and Epigenetics
Grafodatskaya, D., Chung, B., Szatmari, P., & Weksberg, R. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.05.005 · Cited by 235
Epidemiological trends in rates of autism
Fombonne, E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001162 · Cited by 230
Scott, L. J., & Dhillon, S. (2007) · Pediatric Drugs · doi:10.2165/00148581-200709050-00006 · Cited by 228
Rinaldi, T. (2008) · Frontiers in Neural Circuits · doi:10.3389/neuro.04.004.2008 · Cited by 210
Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine
Cummings, C., Stewart, M., Stevenson, M., Morrow, J., & Nelson, J. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2009.176990 · Cited by 205
Narita, N., Kato, M., Tazoe, M., Miyazaki, K., Narita, M., & Okado, N. (2002) · Pediatric Research · doi:10.1203/00006450-200210000-00018 · Cited by 204
Roullet, F. I., Wollaston, L., deCatanzaro, D., & Foster, J. A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.069 · Cited by 200
Self-citationClinical and Macroscopic Correlates of Minicolumnar Pathology in Autism
Casanova, M. F., Buxhoeveden, D. P., & Brown, C. (2002) · Journal of Child Neurology · doi:10.1177/088307380201700908 · Cited by 194
Affect of Seizures During Gestation on Pregnancy Outcomes in Women With Epilepsy
Chen, Y.-H., Chiou, H.-Y., Lin, H.-C., & Lin, H.-L. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.142 · Cited by 192
Mehta, M. V., Gandal, M. J., & Siegel, S. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026077 · Cited by 185
Hyperconnectivity of Local Neocortical Microcircuitry Induced by Prenatal Exposure to Valproic Acid
Rinaldi, T., Silberberg, G., & Markram, H. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm117 · Cited by 184
A male with fetal valproate syndrome and autism
Williams, P. G., & Hersh, J. H. (1997) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1997.tb07500.x · Cited by 178
Circadian rhythms and sleep in children with autism
Glickman, G. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.017 · Cited by 171
Harden, C. L., Pennell, P. B., Koppel, B. S., Hovinga, C. A., Gidal, B., Meador, K. J., Hopp, J., Ting, T. Y., Hauser, W. A., Thurman, D., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02130.x · Cited by 170
Reduced scent marking and ultrasonic vocalizations in the BTBR T+tf/J mouse model of autism
Wöhr, M., Roullet, F. I., & Crawley, J. N. (2011) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00582.x · Cited by 169
Self-citationBehavior and serotonergic disorders in rats exposed prenatally to valproate: A model for autism
Dufour-Rainfray, D., Vourc’h, P., Le Guisquet, A.-M., Garreau, L., Ternant, D., Bodard, S., Jaumain, E., Gulhan, Z., Belzung, C., Andres, C. R., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.054 · Cited by 168
Child development following in utero exposure: Levetiracetam vs sodium valproate
Shallcross, R., Bromley, R. L., Irwin, B., Bonnett, L. J., Morrow, J., & Baker, G. A. (2011) · Neurology · doi:10.1212/wnl.0b013e3182088297 · Cited by 161 · cited 8×
“…these findings, another study reported that VPA (mean dose 800 mg; range 200–1600 mg) exposure was associated with reduced overall developmental scores in comparison to children exposed to levetiracetam (mean dose 1700 mg; range 250–4000 mg), or healthy control children (Shallcross et al., 2011).”
BackgroundMethodInfluentialFoetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age
Meador, K. J., Baker, G. A., Browning, N., Cohen, M. J., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., et al. (2011) · Brain · doi:10.1093/brain/awq352 · Cited by 159
Yu, I. T., Park, J.-Y., Kim, S. H., Lee, J.-S., Kim, Y.-S., & Son, H. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.09.019 · Cited by 158
Risk factors for autism: translating genomic discoveries into diagnostics
Scherer, S. W., & Dawson, G. (2011) · Human Genetics · doi:10.1007/s00439-011-1037-2 · Cited by 142
Harden, C. L., Hopp, J. L., Ting, T. Y., Pennell, P. B., French, J. A., Hauser, W. A., Wiebe, S., Gronseth, G., Thurman, D. J., Meador, K. J., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02128.x · Cited by 141
Use of Antiepileptic Medications in Pregnancy in Relation to Risks of Birth Defects
Werler, M. M., Ahrens, K. A., Bosco, J. L. F., Mitchell, A. A., Anderka, M., Gilboa, S. M., & Holmes, L. B. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.08.002 · Cited by 139
Marinova, Z., Ren, M., Wendland, J. R., Leng, Y., Liang, M., Yasuda, S., Leeds, P. R., & Chuang, D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06385.x · Cited by 132
Language skills of school-aged children prenatally exposed to antiepileptic drugs
Nadebaum, C., Anderson, V., Vajda, F. J. E., Reutens, D. C., Barton, S., & WOOD, A. G. (2011) · Neurology · doi:10.1212/wnl.0b013e31820d62c7 · Cited by 120
The Australian Register of Antiepileptic Drugs in Pregnancy: The first 1002 pregnancies
Vajda, F. J. E., Hitchcock, A. A., Graham, J. E., O'Brien, T. J., Lander, C. M., & Eadie, M. J. (2007) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2007.00781.x · Cited by 116
Kolozsi, E., Mackenzie, R. N., Roullet, F. I., Decatanzaro, D., & Foster, J. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.021 · Cited by 110
Self-citationNadebaum, C., Anderson, V. A., Vajda, F. J. E., Reutens, D. C., Barton, S., & WOOD, A. G. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710001359 · Cited by 105
Zhang, Y., Sun, Y., Wang, F., Wang, Z., Peng, Y., & Li, R. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0724-2 · Cited by 101
Epigenetic modifications in valproic acid-induced teratogenesis
Tung, E. W. Y., & Winn, L. M. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.08.001 · Cited by 99
Tsujino, N., Nakatani, Y., Seki, Y., Nakasato, A., Nakamura, M., Sugawara, M., & Arita, H. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.10.018 · Cited by 99
Narita, M., Oyabu, A., Imura, Y., Kamada, N., Yokoyama, T., Tano, K., Uchida, A., & Narita, N. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.09.001 · Cited by 94
Pregnancy in women who have epilepsy
Pennell, P. B. (2004) · Neurologic Clinics · doi:10.1016/j.ncl.2004.07.004 · Cited by 74
Altered morphology of motor cortex neurons in the VPA rat model of autism
Snow, W. M., Hartle, K., & Ivanco, T. L. (2008) · Developmental Psychobiology · doi:10.1002/dev.20337 · Cited by 72
Sui, L., & Chen, M. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.01.011 · Cited by 71
Mouse Models of Autism: Testing Hypotheses About Molecular Mechanisms
Roullet, F., & Crawley, J. N. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_113 · Cited by 68
Self-citationChanging patterns of antiepileptic drug use in pregnant Australian women
Vajda, F. J. E., Hollingworth, S., Graham, J. E., Hitchcock, A. A., O’Brien, T. J., Lander, C. M., & Eadie, M. J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01260.x · Cited by 67
Go, H. S., Seo, J. E., Kim, K. C., Han, S. M., Kim, P., Kang, Y. S., Han, S. H., Shin, C. Y., & Ko, K. H. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-48 · Cited by 67
Discrimination learning and reversal of the conditioned eyeblink reflex in a rodent model of autism
Stanton, M. E., Peloso, E. D., BROWN, K., & Rodier, P. M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.10.022 · Cited by 61
Antiepileptic drug use during pregnancy: Perinatal outcomes
Kulaga, S., Sheehy, O., Zargarzadeh, A. H., Moussally, K., & Bérard, A. (2011) · Seizure · doi:10.1016/j.seizure.2011.06.012 · Cited by 57
Okada, A., Kushima, K., Aoki, Y., Bialer, M., & Fujiwara, M. (2005) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20131 · Cited by 55
Swim stress exaggerates the hyperactive mesocortical dopamine system in a rodent model of autism
Nakasato, A., Nakatani, Y., Seki, Y., Tsujino, N., Umino, M., & Arita, H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.11.043 · Cited by 54
Neural crest cell motility in valproic acid
Fuller, L. C., Cornelius, S. K., Murphy, C. W., & Wiens, D. J. (2002) · Reproductive Toxicology · doi:10.1016/s0890-6238(02)00059-x · Cited by 51
Frisch, C., Hüsch, K., Angenstein, F., Kudin, A. P., Kunz, W. S., Elger, C. E., & Helmstaedter, C. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01943.x · Cited by 45
Kou, Y., Betancur, C., Xu, H., Buxbaum, J. D., & Ma’ayan, A. (2012) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31330 · Cited by 44
Effects of in Utero Antiepileptic Drug Exposure
Meador, K. J. (2008) · Epilepsy Currents · doi:10.1111/j.1535-7511.2008.00273.x · Cited by 42 · cited 16×
“Due to the teratogenic effects of AEDs, several large-scale pregnancy registries were established to study prevalence of use and the impact of AEDs on pregnancy outcomes.”
BackgroundInfluentialWalcott, E. C., Higgins, E. A., & Desai, N. S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1341-11.2011 · Cited by 41
The prescribing of antiepileptic drugs for pregnant Australian women
Vajda, F. J. E., Horgan, D., Hollingworth, S., Graham, J. E., Hitchcock, A. A., Roten, A., O'Brien, T. J., LANDER, C. M., & Eadie, M. J. (2011) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2011.01359.x · Cited by 28
Tashiro, Y., Oyabu, A., Imura, Y., Uchida, A., Narita, N., & Narita, M. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.03.008 · Cited by 24
Early valproic acid exposure alters functional organization in the primary visual cortex
Pohl‐Guimarães, F., Krahe, T. E., & Medina, A. E. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.025 · Cited by 16
Antiepileptic Treatment in Pregnant Women: Morphological and Behavioural Effects
Tomson, T., & Battino, D. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-20195-0_15 · Cited by 8
Rodier (1996) · doi:10.1002/(sici)1096-9861(19960624)370:2<247::aid-cne8>3.0.co;2-2
Cited by
The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis
Stilling, R. M., van de Wouw, M., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.011 · Cited by 891
Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797
The bowel and beyond: The enteric nervous system in neurological disorders
Rao, M., & Gershon, M. D. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.107 · Cited by 629
The valproic acid-induced rodent model of autism
Nicolini, C., & Fahnestock, M. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.017 · Cited by 592
Altered gut microbiota and activity in a murine model of autism spectrum disorders
de Theije, C. G. M., Wopereis, H., Ramadan, M., van Eijndthoven, T., Lambert, J., Knol, J., Garssen, J., Kraneveld, A. D., & Oozeer, R. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.12.005 · Cited by 433
Metadata
- Authors
- Roullet, F. I., Lai, J. K. Y., & Foster, J. A.
- Venue
- Neurotoxicology and Teratology
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 36
- Pages
- 47-56
- ISSN
- 0892-0362 (ISSN-L)
- OpenAlex
- W2050260157
- Cited by
- 429
- References
- 84
- FWCI
- 27.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.